Repros Therapeutics (RPRX) is a development stage biopharmaceutical company. It is focused on the development of new drugs to treat hormonal and reproductive system disorders. This stock is trading up 14% at $4.77 in recent trading.
Today's Range: $4.45-$4.8552-Week Range: $3.34-$6.74 Volume: 655,000 Three-Month Average Volume: 67,613 Shares of RPRX are ripping higher today after the company announced on Wednesday that it has held a meeting with the Division of Reproductive and Urologic Products or DRUP to agree upon the registration requirements for the company's Androxal oral therapy for the treatment of secondary hypogonadism. >>7 Stocks Soaring in a Weak Market From a technical perspective, RPRX is gapping up sharply higher here on monster volume. This move has pushed RPRX back above both its 50-day and 200-day moving averages. It's also pushed RPRX into breakout territory since the stock has moved above some near-term overhead resistance at $4.50 to $4.70. Traders should continue to look for long-biased trades as long as RPRX is trending above $4.50 to $4.70 with strong upside volume flows, and if the stock can manage to close near or above its daily high of $4.90. If we continue to see that price action, then RPRX has a great chance of tagging its 2012 high of $5.36.